Myriad Genetics (MYGN) stock is downgraded from a "Buy" to "Hold" due to flat Q3 2025 earnings and limited near-term revenue ...

GBP/USD has managed to keep pumping the brakes at the outset of another trading week, finding enough friction to hold off on ...

Richer, older Americans are carrying US consumer spending as income growth for the young slows. It’s now showing up in the ...

EverQuote is emerging from its subscale phase, leveraging operating scale and market tailwinds for sustained double-digit ...

That town is Calvert, a historic community along Highway 6 between Waco and College Station. With just 969 residents, Calvert ...

Soon after returning to the White House, Mr. Trump issued a sweeping order to halt all leasing of federal lands and waters ...

Ukraine Business Roundup newsletter.Ukraine is considering a cocktail of ideas to keep its finances afloat while it waits for ...

Whether we’re officially in a recession might still be something for economists to debate, but what can designers do now to ...

Bitcoin price is down 17% from its all-time high on Tuesday, dropping under $104,000. Crypto liquidations totaled $1.3 ...

BioInvent International (OM:BINV) remains unprofitable, with net losses having expanded at a pace of 27.2% per year over the past five years and no improvement in profit margins during that period.